Clinicopathological indices to predict hepatocellular carcinoma molecular classification

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) is the second most lethal cancer due to lack of effective therapies. Although promising, HCC molecular classification, which enriches potential responders to specific therapies, has not yet been assessed in clinical trials of anti-HCC drugs. We a...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Liver Int
Κύριοι συγγραφείς: Tan, Poh Seng, Nakagawa, Shigeki, Goossens, Nicolas, Venkatesh, Anu, Huang, Tiangui, Ward, Stephen C., Sun, Xiaochen, Song, Won-Min, Koh, Anna, Canasto-Chibuque, Claudia, Deshmukh, Manjeet, Nair, Venugopalan, Mahajan, Milind, Zhang, Bin, Fiel, Maria Isabel, Kobayashi, Masahiro, Kumada, Hiromitsu, Hoshida, Yujin
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2015
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4674393/
https://ncbi.nlm.nih.gov/pubmed/26058462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.12889
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια